top of page
AB-MWI-Animal-Health-RGB.png
Zoetis_logo_rgb.png
heroLOGO-TRIO.png
heroIMG-TRIO.png

Enroll today for easy, automated reminders for your clients

Take advantage of our complimentary marketing campaigns, powered by AllyDVM. 

Let us do the work for you!

Sign up now to increase compliance and preventative revenue for your practice with no extra work for you. 
introTRIO.png

Designed for defense

One monthly Simparica Trio chewable does the job of two or three parasiticides in a single chewable—the way pet owners prefer to give preventatives to their dogs.  It provides protection against:

1

2022-06-07_09-22-47.png

Heartworm disease

Ticks* & fleas

Roundworms & hookworms

Infections that may cause Lyme disease by killing deer ticks

†
email1.jpg

Welcome new dogs

Share with your clients just how easy preventative protection can be.

email2 (2).jpg

Repurchase reminders

Send a quick note when your client is due for a refill of Simparica Trio—and a visit to your office. Or give them the option to buy from your online pharmacy.

email3.jpg

Introduce monthly protection

Educate dog owners about the simplicity of Simparica Trio and the benefits of protecting their dog from common parasites in one

single dose.

Get comprehensive coverage for your practice

Check out the automated emails from ProHeart 12 (moxidectin) and Revolution Plus (selamectin and sarolaner topical solution) too!

​

Bringing you more time-saving, automated reminders to help cat and dog owners stay compliant.

SSPcallout-TRIO.jpg
Zoetis Transp.png
AllyDVM-AB-RGB.png
AB-MWI-Animal-Health-RGB.png

IMPORTANT SAFETY INFORMATION: See full Prescribing Information. Use with caution in dogs with a history of seizures. Simparica Trio contains sarolaner, a member of the isoxazoline class, which has been associated with neurologic adverse reactions including tremors, ataxia, and seizures in dogs with or without a history of neurologic disorders. The safe use of Simparica Trio has not been evaluated in breeding, pregnant, or lactating dogs. The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea.

 

MWI, Zoetis and ALLYDVM care about the security and safety of your practice data. All client and patient information will only be used by ALLYDVM to fulfill campaigns. This data will not be sold or shared for any reason.

 

ProHeart and Simparica Trio and Revolution Plus are registered trademarks of Zoetis Services LLC or a related company or licensor.

 

*Amblyomma americanum, Amblyomma maculatum, Dermacentor variabilis, Ixodes scapularis, Rhipicephalus sanguineus.

†Toxocara canis, Toxascaris leonina, Ancylostoma caninum and Uncinaria stenocephala.

 

Resources: 1. Foster Rosenblatt US Quantitative Research Findings Final Report. Data on file. Zoetis Inc.

 

STR-00375R1

bottom of page